Education
About Us
Working with TipRanks
Follow Us
Graft Polymer (UK) PLC (GB:GPL)
:GPL
GPL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $1.41
Previous CloseN/A
Volume150.04K
Average Volume (3M)19.99M
Market Cap
$3.79M
Enterprise Value$765.32K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)806.00K
Price to Earnings (P/E)―
Beta-1.02
Next Earnings
Jun 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding2,295,930,700
10 Day Avg. Volume7,601,014
30 Day Avg. Volume19,985,906
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.59
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Graft Polymer (UK) PLC News
PremiumCompany Announcements
Graft Polymer to Acquire Awakn Life Sciences for Strategic Expansion
PremiumCompany Announcements
Graft Polymer’s Promising Pre-Clinical Results in PTSD Treatment Programme
PremiumCompany Announcements
Graft Polymer Rebrands Amid Strategic Shift and Collaboration
PremiumCompany Announcements
Graft Polymer Advances PTSD Therapeutic Research
PremiumCompany Announcements
Graft Polymer Advances PTSD Treatment Research---
Options Prices
Currently, No data available
---
Ownership Overview
9.12% Insiders
―
Mutual Funds
― Other Institutional Investors
90.88% Public Companies and
Individual Investors
GPL FAQ
What was Graft Polymer (UK) PLC’s price range in the past 12 months?
Graft Polymer (UK) PLC lowest share price was $0.10 and its highest was $1.41 in the past 12 months.
What is Graft Polymer (UK) PLC’s market cap?
Graft Polymer (UK) PLC’s market cap is $3.79M.
When is Graft Polymer (UK) PLC’s upcoming earnings report date?
Graft Polymer (UK) PLC’s upcoming earnings report date is Jun 25, 2025 which is in 61 days.
How were Graft Polymer (UK) PLC’s earnings last quarter?
Graft Polymer (UK) PLC released its earnings results on Sep 13, 2024. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Is Graft Polymer (UK) PLC overvalued?
According to Wall Street analysts Graft Polymer (UK) PLC’s price is currently Overvalued.
Does Graft Polymer (UK) PLC pay dividends?
Graft Polymer (UK) PLC does not currently pay dividends.
What is Graft Polymer (UK) PLC’s EPS estimate?
Graft Polymer (UK) PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Graft Polymer (UK) PLC have?
Graft Polymer (UK) PLC has 2,295,930,700 shares outstanding.
What happened to Graft Polymer (UK) PLC’s price movement after its last earnings report?
Graft Polymer (UK) PLC reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Graft Polymer (UK) PLC?
Currently, no hedge funds are holding shares in GB:GPL
---
Company Description
Graft Polymer (UK) PLC
Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end use markets, from automotive through to medical and are not dependent on one market segment.
---
Technical Analysis
Billington Holdings
―
Ilika plc
―
Jubilee Metals Group
―
Katoro Gold PLC
―
Zenova Group Plc
―
---